Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase
Uffe H. Olesen(Rigshospitalet), Maxwell Sehested(National University Hospital), Wieland Kieß(University Hospital Leipzig), Peter Fristrup(Technical University of Denmark), Jun Yoshino(Shimane University Hospital), Shin‐ichiro Imai(Washington University in St. Louis), Annemette Thougaard, Mette Krogh Christensen, Søren Jensby Nielsen(Aarhus University), Peter Buhl Jensen(Rigshospitalet), Antje Garten(University Hospital Leipzig), Jakob Gramstrup Petersen(Rigshospitalet), Fredrik Björkling(University of Copenhagen)
Cited by 52
Related Papers
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
|Nature|2000|3.5k
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
|Cell|2001|2.7k
NAD+ and sirtuins in aging and disease
|Trends in Cell Biology|2014|1.4k